Literature DB >> 11892078

Allergen immunotherapy.

R E Esch1, J Portnoy.   

Abstract

Allergen immunotherapy plays an important role in the treatment of allergic diseases and asthma. This article is a brief review of the current approaches, including patient and allergen selection, routes of administration, and use of standardized allergen vaccines. New approaches offering potentially useful strategies based on recent studies of T-cell epitopes, cytokines, and anti-IgE and DNA vaccines also are considered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11892078     DOI: 10.1007/s11882-001-0057-8

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  43 in total

1.  Local routes of immunotherapy.

Authors:  J Bousquet
Journal:  Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M       Date:  1999

2.  The use of standardized allergen extracts. American Academy of Allergy, Asthma and Immunology (AAAAI)

Authors: 
Journal:  J Allergy Clin Immunol       Date:  1997-05       Impact factor: 10.793

3.  A controlled trial of immunotherapy for asthma in allergic children.

Authors:  N F Adkinson; P A Eggleston; D Eney; E O Goldstein; K C Schuberth; J R Bacon; R G Hamilton; M E Weiss; H Arshad; C L Meinert; J Tonascia; B Wheeler
Journal:  N Engl J Med       Date:  1997-01-30       Impact factor: 91.245

4.  Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule.

Authors:  A Hejjaoui; H Dhivert; F B Michel; J Bousquet
Journal:  J Allergy Clin Immunol       Date:  1990-02       Impact factor: 10.793

5.  Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever.

Authors:  P S Norman; L M Lichtenstein; D G Marsh
Journal:  J Allergy Clin Immunol       Date:  1981-12       Impact factor: 10.793

6.  Grass pollen specific sublingual/swallow immunotherapy in children: open-controlled comparison among different treatment protocols.

Authors:  V Di Rienzo; P Puccinelli; F Frati; S Parmiani
Journal:  Allergol Immunopathol (Madr)       Date:  1999 May-Jun       Impact factor: 1.667

7.  Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.

Authors:  G Hedlin; G Silber; R Naclerio; D Proud; A M Lamas; P Eggleston; N F Adkinson
Journal:  Clin Exp Allergy       Date:  1990-09       Impact factor: 5.018

8.  Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies.

Authors:  R N Ross; H S Nelson; I Finegold
Journal:  Clin Ther       Date:  2000-03       Impact factor: 3.393

9.  Treatment of cat allergy with T-cell reactive peptides.

Authors:  P S Norman; J L Ohman; A A Long; P S Creticos; M A Gefter; Z Shaked; R A Wood; P A Eggleston; K B Hafner; P Rao; L M Lichtenstein; N H Jones; C F Nicodemus
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

10.  Oral immunotherapy in birch pollen hay fever.

Authors:  E Taudorf; L C Laursen; A Lanner; B Björksten; S Dreborg; M Søborg; B Weeke
Journal:  J Allergy Clin Immunol       Date:  1987-08       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.